We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Expected fall highlights challenges for pharmaceutical companies that experienced pandemic windfall
Central American nation was one of Taipei’s last partners in Washington’s backyard
Four member states including Poland say amended deal is not ‘fair solution’ to surplus of shots
Health secretary confirms acceptance of advice from expert committee to ‘bridge the gap’ to autumn
Fifty organisations form coalition to counter dangerous falsehoods and rebuild trust in science
Employers advised they need to offer more time and flexibility compared with other illnesses
Pharma group is launching 19 drugs over the next 18 months to counteract a sharp fall in sales from pandemic highs
Manufacturers showed during the pandemic that they can deliver low-cost treatments at scale
Pharma group hopes for approval of mRNA vaccine for booster shots
Pascal Soriot criticises pricing agreement with UK health service
UK biotech racing to keep antibody up to date with latest variants
Shortage of doctors with university posts is putting health service on ‘dangerous precipice’
Short-termism and suspicion in parts of government risk our valuable future in precision medicine
Officials row with Pfizer over price as villages struggle to obtain antiviral medication
Starting with primary care, investment combined with modernisation can deliver better outcomes for patients
Effort to improve health supply chain issues that have led to Greece imposing an export ban on drugs
Hong Kong-based lender seeks to cater to mainlanders’ demand for western jabs
Narrow definition of cases leaves claimants on the hook after state-backed policies drop free care
Pharmaceutical groups to part ways with longstanding executives
South Korean vaccine maker looks elsewhere to expand overseas business
High price of treatment and restrictions on medicine developed by Eisai and Biogen will limit patient access initially
Jab developed by CanSinoBio could help nation grappling with a wave of infection
Covid and flu hospitalisations soar over Christmas as emergency service delays worsen
A surge in cases after China lifted restrictions has sparked concerns that a dangerous new strain could emerge
Beijing rejects Brussels’ offer, citing full control of situation
International Edition
